Abstract-While effective in treating some neurological disorders, neuroelectric prostheses are fundamentally limited because they must employ charge-balanced stimuli to avoid evolution of irreversible electrochemical reactions and their byproducts at the interface between metal electrodes and body fluids. Charge-balancing is typically achieved by using brief biphasic alternating current (AC) pulses, which typically excite nearby neural tissues but cannot efficiently inhibit them. In contrast, direct current (DC) applied via a metal electrode in contact with body fluids can excite, inhibit and modulate sensitivity of neurons; however, chronic DC stimulation is incompatible with biology because it violates charge injection limits that have long been considered unavoidable. In this paper, we describe the design and fabrication of a Safe DC Stimulator (SDCS) that overcomes this constraint. The SCDS drives DC ionic current into target tissue via salt-bridge micropipette electrodes by switching valves in phase with AC square waves applied to metal electrodes contained within the device. This approach achieves DC ionic flow through tissue while still adhering to charge-balancing constraints at each electrode-saline interface. We show the SDCS's ability to both inhibit and excite neural activity to achieve improved dynamic range during prosthetic stimulation of the vestibular part of the inner ear in chinchillas.
I. INTRODUCTION
P ACEMAKERS, cochlear implants, and essentially all other chronically implanted neuroelectric prostheses used in clinical settings rely on charge-balanced, biphasic pulses or other forms of alternating current (AC) to excite neural or muscular activity without driving electrochemical reactions that would otherwise liberate toxic substances at the electrode-saline interface [1] , [2] . All of these devices are constrained to excite the neural tissue in which they are implanted. Inhibition is difficult to achieve with these devices, because the need to avoid a net charge flow above a small charge injection threshold (e.g., electrode area for platinum electrodes [3] - [5] ) mandates the use of brief, charge-balanced pulses for which the cathodic, excitatory phase dominates the neural response.
When the target neural tissue is spontaneously active and the therapeutic goal is to inhibit activity, AC neuroelectric prostheses such as deep brain stimulators (DBS) [6] and spinal cord stimulators (SCS) [7] , [8] typically work indirectly by exciting a set of neurons that then trans-synaptically inhibit the actual target or by driving a set of afferent neurons at supernormal rates to engender downstream adaptive changes that allow encoding of inhibition through withdrawal of excitation. Alternatively, high-frequency pulse trains (1-30 kHz) have been used to create nerve conduction block; however, broad application of that approach is constrained by the relatively high current required to achieve effective block and by the long ( 10 s) excitatory phase typically associated with the onset of stimulation [9] - [11] .
A neural prosthesis that can both excite and inhibit neural tissue could dramatically improve treatment of many neurologic deficits. For example, prostheses to assist micturition should simultaneously excite sacral nerves to activate the detrusor muscle and inhibit lumbar nerves to relax the urethral sphincter [11] . Prostheses intended to restore balance and stable vision through action on the inner ear vestibular afferent fibers require not only excitation to encode head motion toward the implanted side of the head but also inhibition to encode head motion in the opposite direction [12] . Several highly prevalent disorders characterized by uncontrolled neural firing rates (such as tinnitus [13] , chronic pain [14] , and epilepsy [15] ) could be effectively treated by implantable prostheses capable of neural inhibition.
Anodic direct current (DC) delivered by an extracellular electrode near target tissue is very effective at inhibiting neural activity, and continuous cathodic DC can excite neural activity in a graded, stochastic fashion unlike the deterministic, phaselocked behavior elicited by pulsatile stimuli. Given these advantages, DC has long been a mainstay of laboratory experiments, in which the charge-balance constraints imposed on chronically implanted medical devices can be ignored (at the expense of eventual electrode corrosion and neuronal death) or overcome through the use of electrodes that are very large or otherwise incompatible with chronic implantation. Unfortunately, DC stimulation protocols have not been available to implantable medical device designers during most of the 54 years since the first successful demonstration of a chronically implanted pacemaker [16] . An elegant solution to this dilemma was initially described as a method for treating sensorineural hearing loss by Spelman et al., who created a switching network that effectively delivered DC ionic flow into target tissue by switching mechanical valves in phase with AC square waves applied to metal electrodes immersed in an ionic solution [17] , [18] . Based on this idea, we designed and built a Safe DC Stimulator (SDCS) prototype, the SDCS1, and salt-bridge tube electrodes to deliver the stimulation to the tissue. In this manuscript SDCS refers to the concept of the Safe Direct Current Stimulator, while SDCS1 refers to the physical prototype of this concept.
In a bench experiment we tested the complete SDCS1 prototype with the tube electrodes. We also tested the complete SDCS1 system with the tube electrodes in an in vivo experiment showing the complete system's ability to both excite and inhibit the vestibular nerve. In two additional animal experiments we examine the use of direct current delivered via the tube electrodes, but using a standard DC current source to suppress the vestibular nerve activity for an alternative use of DC stimulation in a vestibular prosthetic application.
II. SAFE DIRECT CURRENT STIMULATOR PROTOTYPE

A. Safe DC Concept
Conceptually, the SDCS delivers alternating current pulses to electrodes suspended at the opposite ends of a torus filled with ionic solution ("saline" in Fig. 1 ). With each change in stimulation polarity, valves on either side of each electrode switch from open-to-closed or vice versa, effectively modulating the path for ionic flow through each valve between low impedance and high impedance. Two extension tubes connect the sides of the torus to body fluids to complete the ionic current circuit. Fig. 1 demonstrates this concept and illustrates the two states of the apparatus. In both states, ionic current flows from left to right through the implanted tissue. In this way, a continuous AC square wave controlling the apparatus can deliver approximately DC ionic current through the tissue from left to right.
B. SDCS1Prototype
To confirm that an SDCS can deliver ionic DC current as intended, we built and bench-tested a prototype of the SDCS, the SDCS1. The current required to achieve the physiological response depends on the proximity of the electrode to the stimulated tissue. We estimated from our previous experiments with pulsatile stimulation of the vestibular nerve that the DC current needed to achieve the minimum desired vestibulo-ocular reflex eye response (50 ) would be based on the strength duration curves [19] . Our key requirement for the system was to deliver at least 100 to the target tissue. Fig. 2(a) shows the two states of the device corresponding to the states schematized in Fig. 1 . We used normally-closed valves interconnected with silicone surgical tubing filled with 0.9% NaCl aqueous solution. The silicone tubing was connected to the valves with Tube X standard brass plumbing fittings. Two of the fittings were used as electrodes and , each effectively establishing approximately 700 mm interface area in contact with the saline that filled the device.
The valves (Model DDB-CD-12VDC, Ehcotech International Inc., San Diego, CA, USA) were well suited for building the prototype because they contained no metal parts in contact with the fluid and therefore could not create undesired electrical conduction paths, they responded quickly and the electrical impedance in the closed state was approximately 4 as great as in the open state. Each valve was operated from a 12 V source and consumed 500 mA. We measured the impedance and response time of each valve by clamping off the tubing with hemostatic clamps and connecting a 5 V source across the fittings on each side of the valve. We measured the ionic current passed through the valve when the valve was closed and when it was open for 2 s each. The time to open each valve was 8. 3 2.4 ms. The shut-off settling time was 37 8 ms and this period was characterized by several diminishing oscillations (i.e., ringing) as the plunger within the valve bounced after being released from the solenoid that held the valve open. In the open state, the valve impedance was 1600 210 . In the closed state the valve impedance was measured at 6340 1830 .
The valves were operated using the circuit on the bottom right of the diagrams in Fig. 2 Valve operation was synchronized to electrode polarity changes because the valves were controlled by the square wave AC signal applied to the electrodes and . Stimulation current from the SDCS1 is delivered to the target tissue using ionic solution rather than metal wires [ Fig. 2(a) and (c)]. To deliver ionic current at high current density via small points of entry into the inner ear, we created a modified and miniaturized version of the separated interface nerve electrodes described by Ackerman et al. [20] . To prepare these tube electrodes (TE) we filled Eppendorf 20 capillary tubes (0.25 mm OD, 0.2 mm ID) with a sterile mixture of agar and artificial perilymph [21] to mimic the ionic profile of the labyrinthine fluid. While the gel freely conducts the ionic current from the SDCS1, it resists fluid motion in and out of the tube and it offers a physical barrier to biological contamination of the implanted tissue. We found the electrical impedance of the various lengths of the electrodes by measuring the voltage needed to deliver 100 , 2 s current pulses through a 22 gauge stainless steel needle inserted into the wide portion of the electrode. The impedance ranged proportionally from 72 k for a 15 mm length tube to 360 k for the full length 65 mm electrode.
Because the valve impedance in both the closed and the open state is approximately 100 lower than the electrode impedance, most of the current flowing between the electrodes and is consumed by the leakage through the valves rather than delivered through the tissue. To deliver the required 100 through the 65 mm tube electrodes into the tissue we calculated that we needed to generate 120 V at the electrodes. To drive the current through the system we used two AM2100 biphasic isolated pulse stimulator systems (A-M Systems, Carlsborg, WA, USA), which were synchronized to deliver 0.5 Hz biphasic voltage pulses to the and metal electrodes and provided the control signal for the valve driver circuit. We used voltage control to minimize transients through the system during phase transitions.
The output current of the SDCS1 can vary with the length and the diameter of the tubes that conduct ionic current to the tissue, the impedance of the ionic fluid that fills the system, and leakage currents throughout the system. To monitor the output of the SDCS, we developed and calibrated a current sensing element (CSE) [ Fig. 2(b) ]. This sensor is functionally analogous to a "sense resistor" used in electronic circuits. It is inserted in line at the system output to the tissue as shown in Fig. 2(a) . The sensor is composed of two stainless steel hollow tubes that serve as sensing electrodes at the opposite ends of a silicone tube filled with conductive gel. The conductive gel creates a salt bridge that allows the ions to flow through, but maintains the structural integrity and constant impedance of the CSE. The CSE conduction gel in our system was composed of 0.9% NaCl saline mixed with LB-Agar Medium (Q-Bio gene, Carlsbad, CA, USA) at approximately 0.1 g/ml. The voltage between the two sensing electrodes is proportional to the ionic current through the sensor. This voltage is measured differentially to monitor the output current of the system. We used the differential amplifier symbol to emphasize the need to sense the potential between the sensing electrodes differentially. In our SDCS1 prototype we used a Tektronix TPS 2014 battery powered digital oscilloscope to ensure the measurement isolation from the stimulation circuitry.
III. METHODS
A. SDCS1 and Tube Electrodes Bench Test
We calibrated the CSE using an AM2200 constant current source (A-M Systems, Carlsborg, WA, USA) passing 0 to 70 via large metal electrodes (22 gauge stainless steel needles) through saline-filled surgical tubes connected to a saline bath via a CSE [ Fig. 2(b) ]. We recorded the output of CSE in two cases to ensure that the output of the CSE did not depend on the diameter (and therefore impedance) of the output electrodes. In one case the CSE was connected to the bath with large caliber surgical tubing and in the other case we used the microcatheter electrodes shown in Fig. 2(c) . The latter case is diagrammed in Fig. 2(b) .
To test the SDCS1's ability to drive direct ionic current at the output of the system using AC at the metal electrodes, we measured ionic current flow using the CSE through a saline bath emulating stimulated tissue under three conditions: 1) all valves closed (which should block all current flow), 2) A valves open and B valves closed (which should yield a square wave AC ionic current, and 3) normal operation with valves switching in synchrony with the square wave driving current applied to the electrodes (which should yield DC ionic current).
B. SDCS1 and Neural Modulation In Vivo
While SCDS is a general-purpose stimulation technology with potentially broad applications, our goal in the present study was to characterize the SDCS1's performance using an already well-characterized in vivo preparation that could benefit from the additional capabilities DC allows. We, therefore, studied the use of DC modulation in application to prosthetic stimulation of the vestibular nerve, an application with which we have significant experience [22] - [37] and for which SCDS1's ability to inhibit spontaneous activity would be especially advantageous. In the first experiment, we tested the ability of the tube electrodes to deliver current for a prolonged duration. In the second experiment, we used a pulse-frequency modulated vestibular prosthesis concurrently with DC stimulation delivered to the vestibular nerve to increase the dynamic range of the responses. In the third, experiment we tested the complete SDCS1 system with the tube electrodes to excite and inhibit the vestibular nerve.
Normally, the vestibular system helps the eyes maintain visual acuity by stabilizing gaze via the VOR during head rotations in any direction using sensory input from the vestibular labyrinths in both ears. Sensation of head rotation generates signals that control the extraocular muscles of each eye. In a normal chinchilla, vestibular nerve afferents maintain spontaneous firing at an average 60 spikes/s [38] . Primary afferent neuron firing rates on one side of the head increase when the head rotates toward that side and decrease when the head rotates in the opposite direction. The VOR driven by these changes in firing rate moves the eyes at same speed as the head but in the opposite direction. Three vestibular nerve branches in each inner ear deliver information from three orthogonally oriented semicircular canals (SCC) and encode head rotation about the three corresponding head rotation axes [12] , [39] . Monitoring eye movement velocity and direction is a sensitive, specific and efficient assay of vestibular nerve afferents' excitation and inhibition [40] .
Four adult wild-type 450-650 g chinchillas (Chinchilla lanigera) were studied. Surgical procedures were conducted in accordance with a protocol approved by the Johns Hopkins Animal Care and Use Committee and described in detail previously [27] . Only deviations from the previously published technique are detailed here. In brief, under general anesthesia a phenolic post for head restraint was positioned in the midline perpendicular to the skull at the bregma and embedded in dental cement extruded into each bulla.
One of the chinchillas was implanted with PtIr stimulating wire electrodes in each SCC of the left labyrinth. Twisted pairs of wire electrodes [ Fig. 2(c) ] were implanted for redundancy, but only one was wire used at any one time for stimulation. A monopolar near reference electrode was placed in the common crus and an alternate distant reference electrode was placed in neck musculature. In the other four chinchillas, saline/agar tube electrodes [ Fig. 2(c) ] were implanted in the vestibular labyrinths instead of PtIr wire electrodes. The small outer diameter of the tubes allows intralabyrinthine implantation near the SCC branches of the vestibular nerve [41] . A total of five tube electrodes were implanted: one in each of the three SCCs, one near reference in the vestibule, and one distant reference in neck musculature. Electrodes were secured using dental cement. Plugs in each tube and a plastic cap attached to the phenolic post protected the tube electrodes between experiments.
A real-time, binocular 3-D video-oculography (3D VOG) system modified slightly from one described previously in detail [35] was used for recording eye movements in response to electrical stimulation of the SCCs. The output of this system indicates the eye velocity about each of three axes corresponding approximately to the axes of the semicircular canals: horizontal (H), left anterior/right posterior (LARP), and right anterior/left posterior (RALP).
1) DC Stimulation via Tube Electrodes:
To test the ability of the tube electrodes alone (independent of the SCDS1) to conduct DC ionic current in vivo for a prolonged duration, we used an AM2200 to deliver DC via large surface area metal electrodes inserted into shanks of tube electrodes in one animal. In this case, rather than having the tube electrodes submerged in a saline bath as in Fig. 2(b) , one was implanted in the left anterior SCC near the vestibular nerve, and a return tube electrode was positioned in the vestibule farther away from the vestibular nerve. We hypothesized that long duration DC stimuli via the tubes would not cause a subsequent degradation in performance due to electrode polarization or neural damage, because of the large electrode surface area and long distance between the metal/saline interface and neural tissue in this preparation. We recorded VOR eye responses to ten steps in DC current (1 s duration, 0-80 , anodic at the active electrode) before and after delivering 15 000 s of 80 anodic DC, interrupted occasionally to ensure the animal was not adversely affected by the stimulus. We chose 80 amplitude because this step in DC from 0 evokes strong VOR eye movements without evoking twitches of facial musculature that indicate spurious facial nerve stimulation. We conducted paired t-tests to compare the magnitude and axis of VOR eye rotation in response to the test stimuli before and after the long duration DC presentation.
To confirm that observation of eye movement can detect acute injury due to passage of DC via metal electrodes instead of tube electrodes, we recorded eye movements during and after delivery of 15 s steps of 40 anodic/cathodic DC to one chinchilla via standard PtIr wire electrodes of metal/ saline interface area. We conducted only 10 iterations of this experimental paradigm because the current density of these stimuli was 25 000
, which is two orders of magnitude greater than the standard electrochemical dissolution constraints for the PtIr electrodes that recommend [3] . 2) DC Suppression of Spontaneous Vestibular Nerve Activity via Tube Electrodes: Vestibular prostheses encode head rotation by sensing head velocity with head-fixed gyroscopes and modulating activity on corresponding branches of the vestibular nerve. The standard pulse frequency modulation (PFM) stimulation paradigm used in these devices can readily increase firing rates to encode head rotation toward the implanted side of the head, but encoding head movement away from the implanted side is more challenging, because spontaneous activity sets a floor beneath which an excitatory stimulator cannot down-modulate the nerve. We hypothesized that delivering anodic DC to inhibit spontaneous activity concurrently with PFM would improve the VOR response compared to PFM stimulation alone.
Three chinchillas received pulsatile stimulation delivered via a tube electrode in the left posterior SCC near the posterior ampullary branch of the vestibular nerve. We delivered 60 pulses per second (pps) baseline pulsatile stimulation to the tube electrode using a multichannel vestibular prosthesis with the reference electrode positioned in neck muscles. We then applied 500 ms steps in pulse rate from the 60 pps baseline in 2 s intervals alternating between upward steps (of 100, 200, and 300 pps) and downward steps (of 20, 40, and 60 pps). VOR responses to five steps of each size were acquired. This rate modulation paradigm was then repeated while anodic DC was constantly applied via tube electrodes incorporating large-area metal electrodes.
Current amplitude for the 200 pulsatile stimuli was set at the start of the experiment for each chinchilla by observing VOR responses during 0-400 pps step modulation. The amplitude was set at 66% of the way between the threshold eliciting VOR responses and threshold eliciting facial muscle contraction. These amplitudes were 120, 200, and 250 for chinchillas 1, 2, and 3, respectively. A similar procedure was conducted for the DC stimulation amplitude, resulting in DC stimulation amplitudes set to 100, 80, and 50
, respectively. Once current amplitudes were set for each chinchilla, they were kept constant throughout the experiment.
3) Complete SDCS1 System In Vivo Experiment: Goldberg et al. showed that anodic DC applied via a relatively large silver electrode positioned in perilymph in the inner ear inhibits vestibular primary afferent neuron activity, and that cathodic stimulation excites it [42] . In those studies, the duration of DC current application was limited to 5 s due to charge-injection constraints and electrode polarization. To determine whether the SDCS1 prototype can inhibit and excite neural activity in an analogous in vivo preparation but using implanted tube electrodes, we delivered 5 s pulses of anodic or cathodic currents using SDCS1 connected to a tube electrode positioned near the horizontal branch of the vestibular nerve with the reference tube electrode positioned in neck musculature. We recorded eye movements and monitored the output of the device using the CSE. We expected VOR eye movements to be consistent with vestibular nerve inhibition during anodic stimulation and excitation during cathodic stimulation.
IV. RESULTS
A. SDCS1 and Tube Electrodes Bench Test
The CSE voltage response to ionic current driven through it is shown in Fig. 3(a) . As expected, the voltage across the CSE shows a linear relationship to the DC current through it. CSE voltage when the current was delivered using tube electrodes rather than large-caliber surgical tubing is indicated with red dots on the calibration curve. The CSE accurately tracks electrical current flowing through it for both large caliber, low impedance surgical tubing and for the high impedance tube electrodes used for animal experimentation.
When all valves are closed, current is prevented from flowing to the tissue [ Fig. 3(b) ]. When one set of the valves is held open, the device freely conducts current in both directions [ Fig. 3(c) ]. When the SDCS1 is allowed to operate properly, it delivers rectified ionic DC; however; current flow is interrupted periodically at each phase transition of the AC waveform controlling the device [ Fig. 3(c) ]. These interruptions are 10-50 ms long and most likely result from nonideal valve behavior. Valve transitions are not instantaneous, so complementary valves can be briefly but simultaneously both open causing a short circuit through the ionic bridge. This condition interrupts the current flow through the stimulated tissue.
B. Neural Modulation 1) DC Stimulation via Tube Electrodes: Delivering 40 DC stimulation via 235
(metal) microelectrodes for longer than 10 s was not possible without degrading VOR responses. After four or more presentations of either anodic or cathodic DC via metal electrodes over 10 s long, the animal would exhibit a brisk poststimulation nystagmus (indicative of disruption of normal activity in the implanted labyrinth) lasting 5-15 min, probably due to hydrolysis at the active electrode, which generates bubbles of hydrogen at cathodes and oxygen at anodes.
In contrast, responses to steps in DC current delivered via tube electrodes did not change even after over 15 000 s of continual 80 presentation of anodic DC (Fig. 4) . There was an initial nystagmus associated with the step in long duration DC stimulation that diminished with adaptation within 60 s of stimulation. We did not observe any aberrant VOR responses to test stimuli during the experiment or after 15 000 s of continual DC. Sample responses to stimulation at the beginning and end of the experiment are shown. Neither response amplitude nor response axis changed significantly from before to after the 15 000 s of continual DC (paired t: for amplitude; for angle between initial and final axis compared to zero).
2) DC Suppression of Spontaneous Nerve Activity via Tube Electrodes: Concurrent DC+PFM increased the dynamic range of both inhibitory and excitatory VOR response compared to PFM without DC stimulation (Fig. 5) . For each of the three chinchillas, ch408, ch406, and ch407, maximum inhibitory VOR responses to a 60 pps downward step from baseline pulse rate without DC stimulation were , , and . Responses to the same step improved during concurrent DC to , , and , respectively. Maximum excitatory VOR eye movements in response to a 300 pps increase from baseline without DC stimulation were , , and
. Responses to the same increase in pulse rate improved with DC stimulation to , , and . Results for chinchilla ch408 are presented in Fig. 5(a) for both decrease (plot on the left) and increase (plot on the right) in pulse rate from the 60 pps baseline. When data were aggregated for all three chinchillas [ Fig. 5(b) ], a significant increase in VOR dynamic range with concurrent DC stimulation is apparent both when the pulse rate was decreased by the maximum possible step of 60 pps (ANOVA , post-hoc t-test ) and when the pulse rate was increased by the maximum possible step of 300 pps (ANOVA , post-hoc t-test ).
3) Complete SDCS1 System In Vivo Experiment:
To test the ability of the SDCS1 to both suppress and excite the vestibular nerve we delivered anodic and cathodic pulses to the tube electrode implanted near the horizontal branch of the vestibular nerve. Fig. 6 shows VOR responses confirming that cathodic Safe DC excites and anodic Safe DC inhibits vestibular nerve activity. Insets in Fig. 6 show sample horizontal VOR eye velocity traces of chinchilla ch406 in response to a 35 cathodic step (upper left of the inset) and a 70 anodic step (lower Fig. 6 . VOR responses of chinchilla ch406 to steps of DC delivered using the SCDS1 stimulator connected to a perilymphatic tube electrode and distant reference in neck musculature. Positive current is anodic at the active electrode. Positive eye velocity is rightward and consistent with excitation of the implanted left labyrinth. Anodic DC evokes eye responses consistent with nerve inhibition; cathodic DCevokes responses consistent with nerve excitation. As expected, maximal inhibitory VOR responses are 1/3 of maximal excitatory responses. Brief leftward spikes interrupting the response to cathodic DC are nystagmus quick phases, non-VOR movements that reset eye position when the eyes approach extremes of their range of motion.
right of the inset). The cathodic response reaches a peak slowphase leftward velocity of 270 . The occasional rapid velocity spikes in the opposite direction indicate nystagmus quick phases, which are non-VOR eye movements that reset eye position when the eye reaches the limit of its movement range.
V. DISCUSSION
We presented the concept, initial safety and efficacy data, and a working prototype for a Safe DC neural modulation system. The SDCS1 system delivers ionic DC via flexible microcatheter tube electrodes. It accomplishes this by switching mechanical valves in phase with AC square wave currents applied to metal electrodes immersed in the ionic solution of a bridge rectifier. Whereas passage of DC into the vestibular labyrinth via traditional metal microelectrodes elicited signs of inner ear injury within 10 s of onset, DC presented via saline-bridge tube microelectrodes elicited no signs of injury even after presentations lasting 15 000 s, or 3 orders of magnitude above the duration allowed by classic charge injection constraints.
We demonstrated the efficacy of Safe DC as an adjunct to traditional vestibular prosthesis stimulation paradigms, which have so far been based on PFM alone. Concurrent DC+PFM stimulation, in which Safe DC is used to reduce or silence natural spontaneous activity so that traditional PFM stimuli can more completely control vestibular afferent firing rates, improved both the inhibitory and excitatory dynamic range of VOR responses. Improvements we observed in VOR during DC+PFM are consistent with DC suppression of the vestibular nerve spontaneous activity. For inhibitory PFM stimuli, DC suppression likely facilitated PFM encoding by driving afferent spontaneous activity down, allowing down-modulation of PFM rates to better mimic normal encoding of inhibitory head movements. For excitatory PFM stimuli, DC suppression likely facilitated PFM encoding allowing up-modulation of PFM rates to start from a lower effective baseline (i.e., the 60 pps PFM baseline, rather than the combination of baseline PFM and spontaneous activity), avoiding the lower sensitivity region of the sigmoidal VOR/spike rate relationship, which saturates at higher spike rates [38] .
We demonstrated that the complete prototype SDCS1 system with the tube electrodes can evoke both excitatory and inhibitory VOR responses. As expected, the dynamic range for inhibitory Safe DC is 1/3 of the range for excitatory Safe DC. This is probably because vestibular afferents normally maintain a spontaneous rate of 60 sp/s; excitation with cathodic DC can increase this rate up to 350 sp/s, but inhibition with anodic DC can only decrease it to 0 sp/s.
A. Opportunities for Device Improvement
SDCS1 in its present form presents several technical challenges to overcome before the SDCS concept can be extended to chronic neuromodulation experiments. First, it is constrained to steps of DC and does not programmatically change polarity or amplitude of the ionic current. Because it is built using laboratory bench equipment and is therefore physically large, it is not easily applied to chronic experiments. Additionally, the fidelity of the DC system output is degraded by periodic interruptions in current flow due to nonideal behavior of SCDS1's mechanical valves. Although infrequent enough ( 1 Hz in SCDS1) to cause negligible impact in the setting of vestibular prostheses encoding head motion via PFM, these 10-50 ms interruptions can evoke volleys of neural activity with each valve transition.
Interruptions in current flow occur because ionic current does not reach tissue when complementary valves are all momentarily open during valve transitions and because switching valve states takes longer than the electrode phase transitions. The output current initially reverses the polarity when the AC signal switches electronically and instantaneously at the electrodes [ Fig. 3(d Faster valves could shorten the duration of current interruptions but would not completely eliminate them. A second-generation SDCS now being developed, the SDCS2 could resolve this problem by effectively running two SDCS1 systems in tandem. In this scheme, while SDCS1A drives current through the tissue, SDCS1B's current source turns off and SDCS1B's valves then switch state. Once the SDCS1B valve transition is complete, SDCS1B energizes its current source, assuming control so that SDCS1A can deactivate its current source prior to switching its valves. This method should prevent interruptions in current flow even with relatively slow valves.
Differences in the ionic flow paths available in different tissues mandate that the SDCS safety be assessed individually for each therapeutic application. SDCS can be thought of as an ion pump that pulls in cations through one tube electrode and deposits them from the other, while shuttling anions in the opposite direction. Since this device does not differentiate between different species of cations or anions, the precise anatomic locations of tube electrodes are important. For example, if one tube electrode is positioned in a high Na+, low K+ concentration environment (like the inner ear's perilymphatic spaces) and the other electrode is positioned in a separate compartment with high K+, low Na+ concentration (like endolymph), then the SDCS could alter the ionic make-up of the two fluids over time. This problem should be avoided by implanting the two tube electrodes as a bipolar pair in a homogeneous environment that does not interpose an impermeable membrane between the two tubes. We estimated that the simple monoatomic ions move through this system at approximately 10 [44] . Given that the SDCS1 uses 1 m of tubing, the ions from one tube should be expelled from the other tube after approximately 100 000 s or 27 h. If the fluid in the SDCS matches ionic concentration of the fluid surrounding the target tissue and the electrodes are positioned near each other, we would expect no changes in the ionic composition of either fluid. Alternatively if the ionic concentrations within the device and the target tissue differ, we would expect the ionic make-up of the fluids within the device and the target tissue to reach a steady state within a day or two. Once an SDCS system can be miniaturized, this time estimate would be considerably reduced.
While the SDCS1 provides a functional demonstration of the SDCS concept, the next generation of the SDCS prototype would need to more closely match the conceptual implantable SDCS to estimate the long-term safety and effectiveness. The rate of the AC phase transitions, type and size of the metal electrodes, and voltages and currents needed to drive the system will be different in a small implantable version of the device than the SDCS1. Increasing the impedance of the closed valves would allow lower voltages to drive the system than those needed to drive the SDCS1 because most of the current in SDCS1 is leaked through the closed valves rather than being delivered to the output of the device. Removing current flow interruptions due to nonideal valve transitions and increasing the valve response rate will allow faster system operation and therefore will reduce the amount of charge transfer at the internal metal electrodes per phase of operation. Finally the monoatomic ions, polarized proteins, as well as any undesired chemical byproducts will diffuse through the small implantable system much faster than through the approximately 1 m of SDCS1 tubing.
Apart from improving the stability of purely DC stimuli, overcoming the problem of transient interruptions in ionic flow would also allow an SDCS system to deliver time-varying, non-DC, cathodic and anodic analog stimulus waveforms by running the system with a relatively high-frequency, pulse-amplitude-modulated square wave current source. Although this would offer no major benefit over traditional metal microelectrodes when the analog stimulus waveforms of interest are of high enough frequency to allow adherence to charge injection constraints (e.g., as used in early cochlear implants employing the "sinusoidal analog stimulation" [SAS] paradigm with audio frequency stimuli) [43] , a "low frequency AC" variant of SDCS would allow the use of analog stimulus waveforms in vestibular prostheses, retinal prostheses and other settings in which the analog signals of interest are well below 1 kHz. The entire system should be miniaturized for wearability (e.g., through incorporation of microfluidic MEMS technology [45] ) and battery operation during chronic animal testing. CSE output should provide feedback to a control circuit that adjusts voltage-controlled current sources to ensure constant current at the output of the device. The device should be self-contained and modularized, so that it can serve as a general purpose "back-end" to deliver Safe Direct Current Stimulation for a variety of neural control applications.
B. Potential Applications
Passage of DC from a chronically implanted medical device has long been considered off limits and undesirable. Indeed, it is usually a harbinger of impending device failure and/or tissue injury. The advent of Safe DC could fundamentally change how biomedical engineers design neural prostheses and how clinicians and implant recipients use them. 1) Vestibular Prosthesis: As described earlier, the standard PFM stimulation paradigm used in vestibular prostheses can readily increase firing rates to encode head rotation toward the implanted side of the head, but encoding head movement away from the implanted side is more challenging, because spontaneous activity sets a floor beneath which an excitatory stimulator cannot down-modulate the nerve. Our results suggest that unlike the pulsatile stimulation that can only excite the vestibular afferents, the SDCS could excite and inhibit the vestibular nerve.
2) Pain Control: Spinal cord stimulators (SCS) used for chronic pain control do not have the side effects associated with drug therapies, but only 50% of patients using them report adequate pain control, and all of those report paresthesia (abnormal sensation due to interference with proprioceptive and somatosensory signals) [46] . Unlike SCS that work by stimulating large dorsal column fibers that then inhibit pain transmission through a gating mechanism, anodic DC delivered via tube electrodes near the dorsal root entry zone of the spinal cord could directly inhibit pain transmission at the entry of the pain fibers into the spinal cord.
3) Cortical Stimulation: Transcranial direct current stimulation (tDCS) has demonstrated beneficial effects in a wide range of pathologic conditions, such as stroke, epilepsy, chronic depression, drug cravings, and chronic pain from conditions such as fibromyalgia [47] . SDCS offers a possible alternative to tDCS that can only be applied over short therapy treatments in that implantable SDCS device could chronically deliver excitatory or inhibitory direct current modulation to the cortex.
4) Paralysis and the Inverse Recruitment Problem:
One of the oldest problems in neural engineering has been the "inverse recruitment problem" [48] . Pulsatile stimulation recruits muscles in the reverse of their natural recruitment order. That is the large muscle fibers are recruited at low amplitudes followed by the smaller caliber fibers at higher stimulation currents. SDCS can be used to reverse this stimulation order to the natural recruitment (small to large fibers). This can be done by using the SDCS to apply anodic block to the motor nerve as it is simultaneously receiving complete depolarization from a pulsatile stimulator positioned more proximally on the nerve. As the anodic SDCS block is released, the small caliber fibers will activate first, followed by the larger caliber fibers as the anodic block is released further, thus restoring the proper muscle recruitment order.
VI. CONCLUSION
We designed and built a prototype Safe Direct Current neural stimulator system that delivers direct ionic current via microcatheter tubes filled with ionic gel. Bench tests indicate that the system indeed delivers DC at the output of the system when AC pulses are delivered to each of two metal electrodes within the stimulator. Experimental data obtained in chinchillas suggest that long duration ( 15 000 s) direct current applied to the vestibular nerve via microcatheter tube electrodes did not cause damage to the target neurons, whereas deliver of the same current via similarly sized traditional Pt/Ir metal microelectrodes implanted directly in the ear elicit signs of biologic injury within 10 s. SDCS, therefore, offered at least a 1000-fold improvement over traditional metal electrodes in terms of the total amount of charge passed. Whereas traditional biphasic pulse based stimulators can generally only excite nearby nerves, vestibulo-ocular reflex eye movements in response to cathodic and anodic DC delivered by the SDCS confirm the system's ability to both excite and inhibit neuronal activity. While multiple aspects of the device design and construction will require modification prior to chronic application, the Safe DC approach could open a new realm of possibilities for the design and application of neuroelectronic prostheses.
